<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm: Arthritis</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 7000 RSS medical sources are combined and output via different filters. This feed contains the latest news and research in the Arthritis category.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=arthritis+arthritic&kid=12&t=Arthritis&f=c]]></link>
        <lastBuildDate>Fri, 03 Feb 2012 21:46:11 +0100</lastBuildDate>
        <item>
            <title>Polymorphisms of the TIM-1  gene are associated with rheumatoid arthritis in the Chinese Hui minority  ethnic population.</title>
            <link>http://www.medworm.com/index.php?rid=5653987&amp;cid=c_12_50_f&amp;fid=28401&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22290466%26dopt%3DAbstract</link>
            <description>Polymorphisms of the TIM-1 gene are associated with rheumatoid arthritis in the Chinese Hui minority ethnic population.
    Genet Mol Res. 2012;11(1):61-9
    Authors: Xu JR, Yang Y, Liu XM, Sun JY, Wang YJ
    Abstract
    The T-cell immunoglobulin and mucin domain 1 (TIM-1) is known to be associated with susceptibility to rheumatoid arthritis (RA). We investigated the association of four single-nucleotide polymorphisms (SNPs) in the promoter region of the TIM-1 gene with susceptibility to RA in a Chinese Hui ethnic minority group. Using RFLP or sequence specific primer-PCR, 118 RA patients and 118 non-arthritis control individuals were analyzed for the -1637A&amp;gt;G, -1454G&amp;gt;A, -416G&amp;gt;C, and -232A&amp;gt;G SNPs in the TIM-1 gene. The polymorphisms -232A&amp;gt;G and -1637A&amp;gt;G in the promoter...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Genetics and Molecular Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653987</comments>
            <pubDate>Fri, 03 Feb 2012 11:24:05 +0100</pubDate>
            <guid isPermaLink="false">5653987</guid>        </item>
        <item>
            <title>Switching between anti-TNF-alpha agents does not improve functional capacity in patients with long-standing and active rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5653806&amp;cid=c_12_41_f&amp;fid=37453&amp;url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS0482-50042012000100002%26lng%3Den%26nrm%3Diso%26tlng%3Den</link>
            <description>CONCLUSION: Switching between anti-TNF-alpha agents is a valid strategy to control disease activity, despite the low likelihood of remission and no significant improvement in functional capacity (Source: Revista Brasileira de Reumatologia)</description>
            <author>Revista Brasileira de Reumatologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653806</comments>
            <pubDate>Fri, 03 Feb 2012 10:19:07 +0100</pubDate>
            <guid isPermaLink="false">5653806</guid>        </item>
        <item>
            <title>Reduction in alveolar bone density of patients with juvenile idiopathic arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5653809&amp;cid=c_12_41_f&amp;fid=37453&amp;url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS0482-50042012000100005%26lng%3Den%26nrm%3Diso%26tlng%3Den</link>
            <description>CONCLUSION: ABD was lower in patients with JIA and seemed to be influenced by neither medication nor rheumatic disease activity. In addition, no correlation was observed between ABD and periodontal and rheumatologic clinical parameters (Source: Revista Brasileira de Reumatologia)</description>
            <author>Revista Brasileira de Reumatologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653809</comments>
            <pubDate>Fri, 03 Feb 2012 10:19:07 +0100</pubDate>
            <guid isPermaLink="false">5653809</guid>        </item>
        <item>
            <title>The role of the HLA-G gene and molecule on the clinical expression of rheumatologic diseases</title>
            <link>http://www.medworm.com/index.php?rid=5653813&amp;cid=c_12_41_f&amp;fid=37453&amp;url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS0482-50042012000100009%26lng%3Den%26nrm%3Diso%26tlng%3Den</link>
            <description>O antígeno leucocitário humano G (HLA-G) é uma molécula não clássica de complexo principal de histocompatibilidade (MHC) de classe I, caracterizada por baixo polimorfismo em sua região codificadora, um padrão de distribuição tecidual limitado em condições fisiológicas e expressão por meio de isoformas solúveis e acopladas à superfície de membranas por meio de splicing alternativo. O HLA-G é bastante conhecido por estar envolvido na indução e na manutenção da tolerância entre o sistema imunológico materno e o feto semialogênico ao nível da interface fetoplacentária. Além disso, diversos estudos apontam para um papel imunorregulatório mais amplo dessa molécula. Neste contexto, a expressão de HLA-G em doenças inflamatórias e reumatológicas é uma área relati...</description>
            <author>Revista Brasileira de Reumatologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653813</comments>
            <pubDate>Fri, 03 Feb 2012 10:19:07 +0100</pubDate>
            <guid isPermaLink="false">5653813</guid>        </item>
        <item>
            <title>Current and relevant concepts in psoriatic arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5653814&amp;cid=c_12_41_f&amp;fid=37453&amp;url=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS0482-50042012000100010%26lng%3Den%26nrm%3Diso%26tlng%3Den</link>
            <description>A artrite psoriásica (APs) é uma doença articular sistêmica e polimórfica de apresentação e curso clínico variáveis, associada a comorbidades importantes como diabetes mellitus, hipertensão arterial e dislipidemia. Para o diagnóstico precoce da doença é necessário alto grau de suspeita clínica, sobretudo quando as manifestações cutâneas são sutis e pouco definidas. Doença erosiva progressiva pode ocorrer em até metade dos pacientes, associada a alterações anatômicas e funcionais em cerca de 20%, de modo que o prognóstico da APs permanece obscuro, especialmente se diagnóstico e tratamento forem tardios. Fundamentados em ampla revisão da literatura (PubMed e Lilacs) e experiência dos nossos serviços, novos conceitos de imunogenética, fisiopatologia, aspectos cl...</description>
            <author>Revista Brasileira de Reumatologia</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653814</comments>
            <pubDate>Fri, 03 Feb 2012 10:19:07 +0100</pubDate>
            <guid isPermaLink="false">5653814</guid>        </item>
        <item>
            <title>Neuromodulators for pain management in rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5651687&amp;cid=c_12_35_f&amp;fid=38754&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fpsb.861</link>
            <description>(Source: Prescriber)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Prescriber</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651687</comments>
            <pubDate>Fri, 03 Feb 2012 06:47:12 +0100</pubDate>
            <guid isPermaLink="false">5651687</guid>        </item>
        <item>
            <title>Varus Ankle and Osteochondral Lesions of the Talus</title>
            <link>http://www.medworm.com/index.php?rid=5650951&amp;cid=c_12_31_f&amp;fid=38473&amp;url=http%3A%2F%2Fwww.foot.theclinics.com%2Farticle%2FPIIS1083751511001057%2Fabstract%3Frss%3Dyes</link>
            <description>To our knowledge, little is reported about the management of the patients with combined symptomatic osteochondral lesions of the talus (OLT) and varus ankle malalignment. Treatment strategies for symptomatic OLTs are relatively well described in the orthopaedic literature. While less defined than the surgical management of OLTs, realignment procedures for the varus ankle and hindfoot have also been studied and reported in some detail, albeit with a focus on management of ankle arthritis. In this article we review practical concepts from the orthopaedic literature that may be applied when treating patients with concomitant OLTs and varus ankles malalignment. (Source: Foot and Ankle Clinics)</description>
            <author>Foot and Ankle Clinics</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5650951</comments>
            <pubDate>Fri, 03 Feb 2012 04:48:22 +0100</pubDate>
            <guid isPermaLink="false">5650951</guid>        </item>
        <item>
            <title>Epidemiology, Clinical Manifestations, and Long-Term Outcomes of a Major Outbreak of Chikungunya in a Hamlet in Sri Lanka, in 2007: A Longitudinal Cohort Study</title>
            <link>http://www.medworm.com/index.php?rid=5646688&amp;cid=c_12_3_f&amp;fid=37735&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fjournals%2Fjtm%2F2012%2F639178%2F</link>
            <description>Chikungunya outbreaks occurred in the central province, Sri Lanka in 2006. This community-based study reports the epidemiology and the natural history of the infection from an affected village. Of the 199 families and 1001 individuals in the village, 159 (80&amp;#37;) and 513 (51&amp;#37;) were affected, respectively, comprising 237 (46&amp;#37;) males with peak incidence at 40&amp;#x2013;50 years. The acute illness caused polyarthritis in 233 (46&amp;#37;), and of them 230 (98&amp;#37;) progressed to chronic arthritic disability (CAD). Of the CAD patients, 102 (44&amp;#37;) had recovered in 141 days (range 30&amp;#8211;210 days) from the disability state whilst 128 (56&amp;#37;) had persisting disability which lasted 12, 24, and 36 months in 41 (17.8&amp;#37;), 22 (9.5&amp;#37;), and 14 (6.1&amp;#37;) individuals, respectively. Carpal ...</description>
            <author>Clinical and Developmental Immunology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5646688</comments>
            <pubDate>Thu, 02 Feb 2012 11:21:45 +0100</pubDate>
            <guid isPermaLink="false">5646688</guid>        </item>
        <item>
            <title>Dyspnea Caused by Atlantoaxial Subluxation in  a Patient with Rheumatoid Arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5646694&amp;cid=c_12_3_f&amp;fid=37735&amp;url=http%3A%2F%2Fwww.hindawi.com%2Fcrim%2Fem%2F2012%2F170956%2F</link>
            <description>We report a patient with rheumatoid arthritis whose chief complaint was dyspnea on arrival to the emergency department (ED). After further investigation, spinal cord compression caused by atlantoaxial subluxation was diagnosed. This is an uncommon but important case that ED physicians should be aware of. (Source: Clinical and Developmental Immunology)</description>
            <author>Clinical and Developmental Immunology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5646694</comments>
            <pubDate>Thu, 02 Feb 2012 11:21:45 +0100</pubDate>
            <guid isPermaLink="false">5646694</guid>        </item>
        <item>
            <title>Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)‐1 and an emerging role for cytokines beyond IL‐1</title>
            <link>http://www.medworm.com/index.php?rid=5646592&amp;cid=c_12_3_f&amp;fid=33580&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1111%252Fj.1365-2249.2011.04533.x</link>
            <description>OTHER THEMES PUBLISHED IN THIS IMMUNOLOGY IN THE CLINIC REVIEW SERIESAllergy, Host Responses, Cancer, Type 1 diabetes and viruses, Metabolic diseases.SummaryThe disease‐based discovery of the molecular basis for autoinflammatory diseases has led not only to a rapidly growing number of clinically and genetically identifiable disorders, but has unmantled key inflammatory pathways such as the potent role of the alarm cytokine interleukin (IL)‐1 in human disease. Following its initial failures in the treatment of sepsis and the moderate success in the treatment of rheumatoid arthritis, IL‐1 blocking therapies had a renaissance in the treatment of a number of autoinflammatory conditions, and IL‐1 blocking therapies have been Food and Drug Administration (FDA)‐approved for the treatmen...</description>
            <author>Clinical and Experimental Immunology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5646592</comments>
            <pubDate>Thu, 02 Feb 2012 11:18:22 +0100</pubDate>
            <guid isPermaLink="false">5646592</guid>        </item>
        <item>
            <title>Those Living In Poor  Neighbourhoods Suffer Higher Incidence Of Arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5646830&amp;cid=c_12_26_f&amp;fid=23292&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2FaX-dlKoCfzg%2F241054.php</link>
            <description>Results revealed that people who live in socially disadvantaged areas were 42 per cent more at risk of getting arthritis than people in more affluent areas. The study revealed more than 30 per cent of people living in socially disadvantaged areas reported having arthritis, as opposed to 18.5 per cent in the more affluent areas. Led by the University of Melbourne, Deakin University and Queensland University of Technology, the study was published in the international journal Arthritis Care &amp; Research... (Source: Health News from Medical News Today)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Health News from Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5646830</comments>
            <pubDate>Thu, 02 Feb 2012 09:00:00 +0100</pubDate>
            <guid isPermaLink="false">5646830</guid>        </item>
        <item>
            <title>estrogens conjugated, Premarin</title>
            <link>http://www.medworm.com/index.php?rid=5653767&amp;cid=c_12_41_f&amp;fid=29977&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D811%26k%3DArthritis_General</link>
            <description>Title: estrogens conjugated, PremarinCategory: MedicationsCreated: 12/31/1997Last Editorial Review: 2/2/2012 (Source: MedicineNet Arthritis General)</description>
            <author>MedicineNet Arthritis General</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653767</comments>
            <pubDate>Thu, 02 Feb 2012 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653767</guid>        </item>
        <item>
            <title>sulfamethoxazole and trimethoprim, Bactrim, Septra</title>
            <link>http://www.medworm.com/index.php?rid=5653768&amp;cid=c_12_41_f&amp;fid=29977&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D1994%26k%3DArthritis_General</link>
            <description>Title: sulfamethoxazole and trimethoprim, Bactrim, SeptraCategory: MedicationsCreated: 12/31/1997Last Editorial Review: 2/2/2012 (Source: MedicineNet Arthritis General)</description>
            <author>MedicineNet Arthritis General</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653768</comments>
            <pubDate>Thu, 02 Feb 2012 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653768</guid>        </item>
        <item>
            <title>infliximab, Remicade</title>
            <link>http://www.medworm.com/index.php?rid=5653769&amp;cid=c_12_41_f&amp;fid=29977&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D12005%26k%3DArthritis_General</link>
            <description>Title: infliximab, RemicadeCategory: MedicationsCreated: 12/13/1999 9:40:00 PMLast Editorial Review: 2/2/2012 (Source: MedicineNet Arthritis General)</description>
            <author>MedicineNet Arthritis General</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653769</comments>
            <pubDate>Thu, 02 Feb 2012 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653769</guid>        </item>
        <item>
            <title>Gleevec Approval Widened to Include Rare Cancer</title>
            <link>http://www.medworm.com/index.php?rid=5653770&amp;cid=c_12_41_f&amp;fid=29977&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D154271%26k%3DArthritis_General</link>
            <description>Title: Gleevec Approval Widened to Include Rare CancerCategory: Health NewsCreated: 2/1/2012 4:06:00 PMLast Editorial Review: 2/2/2012 (Source: MedicineNet Arthritis General)</description>
            <author>MedicineNet Arthritis General</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653770</comments>
            <pubDate>Thu, 02 Feb 2012 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653770</guid>        </item>
        <item>
            <title>Specific post-translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies</title>
            <link>http://www.medworm.com/index.php?rid=5653763&amp;cid=c_12_41_f&amp;fid=29968&amp;url=http%3A%2F%2Farthritis-research.com%2Fcontent%2F14%2F1%2FR25</link>
            <description>Conclusions:
Isolated in vivo exposure to NETs is insufficient to break tolerance and may involve additional factors that have yet to be identified. (Source: Arthritis Research and Therapy)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Arthritis Research and Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653763</comments>
            <pubDate>Thu, 02 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653763</guid>        </item>
        <item>
            <title>Sports Activity After Short-Stem Hip Arthroplasty</title>
            <link>http://www.medworm.com/index.php?rid=5653841&amp;cid=c_12_42_f&amp;fid=31472&amp;url=http%3A%2F%2Fajs.sagepub.com%2Fcgi%2Fcontent%2Fabstract%2F40%2F2%2F425%3Frss%3D1</link>
            <description>Conclusion: Patients with a short-stem hip implant can return to a good level of activity postoperatively. Participation in sports almost reached similar levels as preoperatively but with a shift from high- to low-impact activities. This seems desirable from a surgeon&amp;rsquo;s point of view but should also be communicated to the patient before hip replacement. (Source: The American Journal of Sports Medicine)</description>
            <author>The American Journal of Sports Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653841</comments>
            <pubDate>Thu, 02 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653841</guid>        </item>
        <item>
            <title>MicroRNAs in Systemic Rheumatic DiseasesMicroRNAs in Systemic Rheumatic Diseases</title>
            <link>http://www.medworm.com/index.php?rid=5646809&amp;cid=c_12_26_f&amp;fid=36062&amp;url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F756892%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F756892%3Fsrc%3Drss</link>
            <description>MiRNAs are emerging as potential targets for new therapeutic strategies of autoimmune disorders.  Arthritis Research &amp; Therapy (Source: Medscape Today Headlines)</description>
            <author>Medscape Today Headlines</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5646809</comments>
            <pubDate>Thu, 02 Feb 2012 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5646809</guid>        </item>
        <item>
            <title>Linear Pitting and Splinter Haemorrhages Are More Commonly Seen in the Nails of Patients with Established Psoriasis in Comparison to Psoriatic Arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5647962&amp;cid=c_12_12_f&amp;fid=33518&amp;url=http%3A%2F%2Fcontent.karger.com%2Fproduktedb%2Fprodukte.asp%3Fdoi%3D335571</link>
            <description>Dermatology (DOI:10.1159/000335571) (Source: Dermatology)</description>
            <author>Dermatology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647962</comments>
            <pubDate>Wed, 01 Feb 2012 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">5647962</guid>        </item>
        <item>
            <title>Integrated Safety in Tocilizumab Clinical TrialsIntegrated Safety in Tocilizumab Clinical Trials</title>
            <link>http://www.medworm.com/index.php?rid=5653779&amp;cid=c_12_41_f&amp;fid=29980&amp;url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F757500%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F757500%3Fsrc%3Drss</link>
            <description>How safe is tocilizumab in the treatment of rheumatoid arthritis?  Arthritis Research &amp; Therapy (Source: Medscape Rheumatology Headlines)</description>
            <author>Medscape Rheumatology Headlines</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653779</comments>
            <pubDate>Wed, 01 Feb 2012 19:33:07 +0100</pubDate>
            <guid isPermaLink="false">5653779</guid>        </item>
        <item>
            <title>UCB and Astellas Announce Agreement to Jointly Develop and Commercialize Cimzia (Certolizumab Pegol) in Japan</title>
            <link>http://www.medworm.com/index.php?rid=5651504&amp;cid=c_12_34_f&amp;fid=36540&amp;url=http%3A%2F%2Ffeeds.drugs.com%2F%7Er%2FDrugscom-HeadlineNews%2F%7E3%2FLd3v4LmPqro%2Fucb-astellas-announce-agreement-jointly-develop-commercialize-cimzia-certolizumab-pegol-japan-36187.html</link>
            <description>Astellas and UCB partner to bring certolizumab pegol to
rheumatoid arthritis patients in Japan
UCB files certolizumab pegol for marketing authorisation with
the Japanese Ministry of Health, Labour and Welfare
Tokyo, Japan and Brussels, Belgium, 1st... (Source: Drugs.com - Pharma News)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Drugs.com - Pharma News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651504</comments>
            <pubDate>Wed, 01 Feb 2012 12:10:11 +0100</pubDate>
            <guid isPermaLink="false">5651504</guid>        </item>
        <item>
            <title>Arthritis - Whether Weather Affects Arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5646876&amp;cid=c_12_5_f&amp;fid=28818&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D14686%26k%3DChronic_Pain_General</link>
            <description>Title: Arthritis - Whether Weather Affects ArthritisCategory: Doctor's ViewsCreated: 9/10/2000Last Editorial Review: 2/1/2012 (Source: MedicineNet Chronic Pain General)</description>
            <author>MedicineNet Chronic Pain General</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5646876</comments>
            <pubDate>Wed, 01 Feb 2012 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">5646876</guid>        </item>
        <item>
            <title>Rheumatoid Arthritis: Questions for Your Doctor</title>
            <link>http://www.medworm.com/index.php?rid=5646877&amp;cid=c_12_5_f&amp;fid=28818&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D18090%26k%3DChronic_Pain_General</link>
            <description>Title: Rheumatoid Arthritis: Questions for Your DoctorCategory: Doctor's ViewsCreated: 8/6/2001 4:16:00 PMLast Editorial Review: 2/1/2012 (Source: MedicineNet Chronic Pain General)</description>
            <author>MedicineNet Chronic Pain General</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5646877</comments>
            <pubDate>Wed, 01 Feb 2012 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">5646877</guid>        </item>
        <item>
            <title>Arthritis - Whether Weather Affects Arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5649101&amp;cid=c_12_18_f&amp;fid=28417&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D14686%26k%3DSenior_Health_General</link>
            <description>Title: Arthritis - Whether Weather Affects ArthritisCategory: Doctor's ViewsCreated: 9/10/2000Last Editorial Review: 2/1/2012 (Source: MedicineNet Senior Health General)</description>
            <author>MedicineNet Senior Health General</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649101</comments>
            <pubDate>Wed, 01 Feb 2012 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">5649101</guid>        </item>
        <item>
            <title>Rheumatoid Arthritis: Questions for Your Doctor</title>
            <link>http://www.medworm.com/index.php?rid=5649102&amp;cid=c_12_18_f&amp;fid=28417&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D18090%26k%3DSenior_Health_General</link>
            <description>Title: Rheumatoid Arthritis: Questions for Your DoctorCategory: Doctor's ViewsCreated: 8/6/2001 4:16:00 PMLast Editorial Review: 2/1/2012 (Source: MedicineNet Senior Health General)</description>
            <author>MedicineNet Senior Health General</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649102</comments>
            <pubDate>Wed, 01 Feb 2012 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">5649102</guid>        </item>
        <item>
            <title>Nonsteroidal Anti-inflammatory Drugs and Ulcers</title>
            <link>http://www.medworm.com/index.php?rid=5653771&amp;cid=c_12_41_f&amp;fid=29977&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D429%26k%3DArthritis_General</link>
            <description>Title: Nonsteroidal Anti-inflammatory Drugs and UlcersCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 2/1/2012 (Source: MedicineNet Arthritis General)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>MedicineNet Arthritis General</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653771</comments>
            <pubDate>Wed, 01 Feb 2012 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653771</guid>        </item>
        <item>
            <title>Coping With Chronic Rheumatic Diseases</title>
            <link>http://www.medworm.com/index.php?rid=5653772&amp;cid=c_12_41_f&amp;fid=29977&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D14267%26k%3DArthritis_General</link>
            <description>Title: Coping With Chronic Rheumatic DiseasesCategory: Doctor's ViewsCreated: 8/4/2000 3:27:00 PMLast Editorial Review: 2/1/2012 (Source: MedicineNet Arthritis General)</description>
            <author>MedicineNet Arthritis General</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653772</comments>
            <pubDate>Wed, 01 Feb 2012 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653772</guid>        </item>
        <item>
            <title>Arthritis - Whether Weather Affects Arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5653773&amp;cid=c_12_41_f&amp;fid=29977&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D14686%26k%3DArthritis_General</link>
            <description>Title: Arthritis - Whether Weather Affects ArthritisCategory: Doctor's ViewsCreated: 9/10/2000Last Editorial Review: 2/1/2012 (Source: MedicineNet Arthritis General)</description>
            <author>MedicineNet Arthritis General</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653773</comments>
            <pubDate>Wed, 01 Feb 2012 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653773</guid>        </item>
        <item>
            <title>Rheumatoid Arthritis: Questions for Your Doctor</title>
            <link>http://www.medworm.com/index.php?rid=5653774&amp;cid=c_12_41_f&amp;fid=29977&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D18090%26k%3DArthritis_General</link>
            <description>Title: Rheumatoid Arthritis: Questions for Your DoctorCategory: Doctor's ViewsCreated: 8/6/2001 4:16:00 PMLast Editorial Review: 2/1/2012 (Source: MedicineNet Arthritis General)</description>
            <author>MedicineNet Arthritis General</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653774</comments>
            <pubDate>Wed, 01 Feb 2012 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653774</guid>        </item>
        <item>
            <title>Pain (Acute and Chronic)</title>
            <link>http://www.medworm.com/index.php?rid=5653775&amp;cid=c_12_41_f&amp;fid=29977&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D40842%26k%3DArthritis_General</link>
            <description>Title: Pain (Acute and Chronic)Category: Doctor's ViewsCreated: 11/30/2004Last Editorial Review: 2/1/2012 (Source: MedicineNet Arthritis General)</description>
            <author>MedicineNet Arthritis General</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653775</comments>
            <pubDate>Wed, 01 Feb 2012 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653775</guid>        </item>
        <item>
            <title>Heartburn Drugs Linked to Hip Fractures in Women</title>
            <link>http://www.medworm.com/index.php?rid=5653776&amp;cid=c_12_41_f&amp;fid=29977&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D154238%26k%3DArthritis_General</link>
            <description>Title: Heartburn Drugs Linked to Hip Fractures in WomenCategory: Health NewsCreated: 2/1/2012 11:01:00 AMLast Editorial Review: 2/1/2012 (Source: MedicineNet Arthritis General)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>MedicineNet Arthritis General</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653776</comments>
            <pubDate>Wed, 01 Feb 2012 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653776</guid>        </item>
        <item>
            <title>Rheumatoid Arthritis: Questions for Your Doctor</title>
            <link>http://www.medworm.com/index.php?rid=5656674&amp;cid=c_12_71_f&amp;fid=31485&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D18090%26k%3DExercise_and_Fitness_General</link>
            <description>Title: Rheumatoid Arthritis: Questions for Your DoctorCategory: Doctor's ViewsCreated: 8/6/2001 4:16:00 PMLast Editorial Review: 2/1/2012 (Source: MedicineNet Feet and Fitness General)</description>
            <author>MedicineNet Feet and Fitness General</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5656674</comments>
            <pubDate>Wed, 01 Feb 2012 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">5656674</guid>        </item>
        <item>
            <title>[Radiological imaging in early diagnosis of rheumatoid arthritis :  The role of ultrasound and magnetic resonance imaging.]</title>
            <link>http://www.medworm.com/index.php?rid=5646498&amp;cid=c_12_37_f&amp;fid=36278&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22290453%26dopt%3DAbstract</link>
            <description>[Radiological imaging in early diagnosis of rheumatoid arthritis : The role of ultrasound and magnetic resonance imaging.]
    Radiologe. 2012 Feb 1;
    Authors: Platzgummer H, Schüller-Weidekamm C
    Abstract
    CLINICAL/METHODICAL ISSUE:            For optimal therapy management of patients with rheumatoid arthritis (RA) specific and sensitive diagnostic methods are essential for assessment of disease activity.                     STANDARD RADIOLOGICAL METHODS:            In addition to projection radiography, imaging techniques, in particular magnetic resonance imaging (MRI) and ultrasound (US) are becoming increasingly more important for the early diagnosis of RA.                     PRACTICAL RECOMMENDATIONS:            The MRI and US techniques play a key role in the early imagin...</description>
            <author>Der Radiologe</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5646498</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5646498</guid>        </item>
        <item>
            <title>Addition of an indoleamine‐2,3,‐dioxygenase inhibitor to B cell depletion therapy blocks autoreactive B cell activation and recurrence of arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5653785&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.34406</link>
            <description>Conclusion:IDO activity is essential for the differentiation of autoreactive B cells into antibody secreting cells, but is not necessary for their initial stages of activation. Addition of 1MT to B cell depletion therapy prevents the differentiation of autoantibody secreting cells and recurrence of autoimmune arthritis following reconstitution of the B cell repertoire. These data suggest that IDO inhibitors could be used in conjunction with B cell depletion as an effective co‐therapeutic strategy in the treatment of rheumatoid arthritis. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653785</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653785</guid>        </item>
        <item>
            <title>Evaluation of cardiovascular risk in patients with rheumatoid arthritis. Do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?</title>
            <link>http://www.medworm.com/index.php?rid=5653794&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.21631</link>
            <description>Conclusion:Among the biomarkers tested, only anti‐apoA‐1 significantly improved the FRS predictive ability. © 2012 by the American College of Rheumatology. (Source: Arthritis Care and Research)</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653794</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653794</guid>        </item>
        <item>
            <title>Hip pain while using lower extremity joints is associated with sleep disturbances in elderly caucasian women: The study of osteoporotic fractures</title>
            <link>http://www.medworm.com/index.php?rid=5653795&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.21630</link>
            <description>Conclusion:Fragmented sleep was greater in women with hip pain compared to those without hip pain. However, fragmented sleep in women with severe hip pain compared to those without hip pain was unchanged until after the first two hours of sleep. Further investigation, such as pain medications wearing off over time, or prolonged periods of inactivity decreasing the pain threshold are warranted. © 2012 by the American College of Rheumatology. (Source: Arthritis Care and Research)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653795</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653795</guid>        </item>
        <item>
            <title>Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondylarthritis)</title>
            <link>http://www.medworm.com/index.php?rid=5654544&amp;cid=c_12_49_f&amp;fid=38937&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FEvidence%2FDisease-Focused-Reviews%2FPain-management-for-inflammatory-arthritis-rheumatoid-arthritis-psoriatic-arthritis-ankylosing-spondylitis-and-other-spondylarthritis%2F</link>
            <description>Source: Cochrane
Area: Evidence &amp;#62; Disease Focused Reviews
 Background 
  Even with optimal disease-modifying treatment and good control of disease activity, persistent pain due to structural damage is common in people with inflammatory arthritis and therefore additional treatment for pain might be required. Because comorbidity is highly prevalent in people with inflammatory arthritis, it is important to consider comorbidities such as gastrointestinal or liver diseases in deciding upon optimal pharmacologic pain therapy. 
  &amp;#160; 
  &amp;#160; 
 Objectives 
  To assess the efficacy and safety of pharmacological pain treatment in patients with inflammatory arthritis who have gastrointestinal or liver comorbidities, or both. 
  &amp;#160; 
  &amp;#160; 
 Search methods 
  We searched MEDLINE, EMBASE...</description>
            <author>NeLM - Disease Focused Reviews</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5654544</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5654544</guid>        </item>
        <item>
            <title>Synthesis, Anti-Arthritic, and Anti-Inflammatory Activity of N-Tosyl aza Cyclophanes</title>
            <link>http://www.medworm.com/index.php?rid=5655915&amp;cid=c_12_59_f&amp;fid=36763&amp;url=http%3A%2F%2Fwww.publish.csiro.au%2Frss_feed%2FCH11435</link>
            <description>Perumal Rajakumar, Ramar Padmanabhan 

The synthesis of some novel N-tosyl tetra and diaza cyclophanes incorporating m-terphenyl as spacer units is described. All the N-tosyl aza cyclophanes exhibit excellent anti-arthritic and anti-inflammatory activity. (Source: Australian Journal of Chemistry)</description>
            <author>Australian Journal of Chemistry</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5655915</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5655915</guid>        </item>
        <item>
            <title>Biologics, Surgery Offer New Hope in Psoriatic ArthritisBiologics, Surgery Offer New Hope in Psoriatic Arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5645370&amp;cid=c_12_26_f&amp;fid=36062&amp;url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F757877%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F757877%3Fsrc%3Drss</link>
            <description>Early, aggressive treatment may help reduce symptoms and improve joint function.  Medscape Medical News (Source: Medscape Today Headlines)</description>
            <author>Medscape Today Headlines</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5645370</comments>
            <pubDate>Wed, 01 Feb 2012 03:45:00 +0100</pubDate>
            <guid isPermaLink="false">5645370</guid>        </item>
        <item>
            <title>T-cell targeting medication may relieve psoriatic arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5648657&amp;cid=c_12_13_f&amp;fid=36852&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmacyEurope%2F%7E3%2FuedX0ITmX7s%2Fdefault.asp</link>
            <description>Early, aggressive treatment may help reduce symptoms and improve joint function (Source: Pharmacy Europe)</description>
            <author>Pharmacy Europe</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5648657</comments>
            <pubDate>Tue, 31 Jan 2012 11:49:00 +0100</pubDate>
            <guid isPermaLink="false">5648657</guid>        </item>
        <item>
            <title>Rheumatoid Arthritis - When Do I Call the Doctor?</title>
            <link>http://www.medworm.com/index.php?rid=5644849&amp;cid=c_12_161_f&amp;fid=25329&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D17593%26k%3DHearing_General</link>
            <description>Title: Rheumatoid Arthritis - When Do I Call the Doctor?Category: Doctor's ViewsCreated: 7/7/2001 12:46:00 PMLast Editorial Review: 1/31/2012 (Source: MedicineNet Hearing General)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>MedicineNet Hearing General</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5644849</comments>
            <pubDate>Tue, 31 Jan 2012 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">5644849</guid>        </item>
        <item>
            <title>Living With Rheumatoid Arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5646880&amp;cid=c_12_5_f&amp;fid=28818&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D63359%26k%3DChronic_Pain_General</link>
            <description>Title: Living With Rheumatoid ArthritisCategory: Doctor's ViewsCreated: 8/9/2006Last Editorial Review: 1/31/2012 (Source: MedicineNet Chronic Pain General)</description>
            <author>MedicineNet Chronic Pain General</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5646880</comments>
            <pubDate>Tue, 31 Jan 2012 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">5646880</guid>        </item>
        <item>
            <title>Rheumatoid Arthritis - When Do I Call the Doctor?</title>
            <link>http://www.medworm.com/index.php?rid=5647470&amp;cid=c_12_7_f&amp;fid=29189&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D17593%26k%3DCholesterol_General</link>
            <description>Title: Rheumatoid Arthritis - When Do I Call the Doctor?Category: Doctor's ViewsCreated: 7/7/2001 12:46:00 PMLast Editorial Review: 1/31/2012 (Source: MedicineNet Cholesterol General)</description>
            <author>MedicineNet Cholesterol General</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5647470</comments>
            <pubDate>Tue, 31 Jan 2012 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">5647470</guid>        </item>
        <item>
            <title>Living With Rheumatoid Arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5653778&amp;cid=c_12_41_f&amp;fid=29977&amp;url=http%3A%2F%2Fwww.medicinenet.com%2Fguide.asp%3Fs%3Drss%26a%3D63359%26k%3DArthritis_General</link>
            <description>Title: Living With Rheumatoid ArthritisCategory: Doctor's ViewsCreated: 8/9/2006Last Editorial Review: 1/31/2012 (Source: MedicineNet Arthritis General)</description>
            <author>MedicineNet Arthritis General</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653778</comments>
            <pubDate>Tue, 31 Jan 2012 07:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653778</guid>        </item>
        <item>
            <title>Poor neighborhoods suffer higher incidence of arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5646115&amp;cid=c_12_46_f&amp;fid=31012&amp;url=http%3A%2F%2Fwww.eurekalert.org%2Fpub_releases%2F2012-01%2Fuom-pns013112.php</link>
            <description>(University of Melbourne) People living in poor neighborhoods have a higher rate and risk of arthritis - one of the most common causes of disability in the developed world. (Source: EurekAlert! - Social and Behavioral Science)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>EurekAlert! - Social and Behavioral Science</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5646115</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5646115</guid>        </item>
        <item>
            <title>Neuromodulators for pain management in rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5648689&amp;cid=c_12_13_f&amp;fid=38891&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FEvidence%2FDrug-Class-Focused-Reviews%2FNeuromodulators-for-pain-management-in-rheumatoid-arthritis%2F</link>
            <description>Source: Cochrane Library
Area: Evidence &amp;#62; Drug Class Focused Reviews
 Background 
  Pain management is a high priority for patients with rheumatoid arthritis (RA). Despite deficiencies in research data, neuromodulators have gained widespread clinical acceptance as adjuvants in the management of patients with chronic musculoskeletal pain. 
  &amp;#160; 
  &amp;#160; 
 Objectives 
  The aim of this review was to determine the efficacy and safety of neuromodulators in pain management in patients with RA. Neuromodulators included in this review were anticonvulsants (gabapentin, pregabalin, phenytoin, sodium valproate, lamotrigine, carbamazepine, levetiracetam, oxcarbazepine, tiagabine and topiramate), ketamine, bupropion, methylphenidate, nefopam, capsaicin and the cannabinoids. 
 &amp;#160; 
 Search ...</description>
            <author>NeLM - Drug Class Focused Reviews</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5648689</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5648689</guid>        </item>
        <item>
            <title>Muscle relaxants for pain management in rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5648691&amp;cid=c_12_13_f&amp;fid=38891&amp;url=http%3A%2F%2Fwww.nelm.nhs.uk%2Fen%2FNeLM-Area%2FEvidence%2FDrug-Class-Focused-Reviews%2FMuscle-relaxants-for-pain-management-in-rheumatoid-arthritis%2F</link>
            <description>Source: Cochrane Library
Area: Evidence &amp;#62; Drug Class Focused Reviews
 Background 
 Pain management is a high priority for patients with rheumatoid arthritis (RA). Muscle relaxants include drugs that reduce muscle spasm (for example benzodiazepines such as diazepam (Valium), alprazolam (Xanax), lorazepam (Ativan) and non-benzodiazepines such as metaxalone (Skelaxin) or a combination of paracetamol and orphenadrine (Muscol)) and drugs that prevent increased muscle tone (baclofen and dantrolene). Despite a paucity of evidence supporting their use, antispasmodic and antispasticity muscle relaxants have gained widespread clinical acceptance as adjuvants in the management of patients with chronic musculoskeletal pain. 
   &amp;#160; 
   &amp;#160; 
  Objectives The aim of this review was to determin...</description>
            <author>NeLM - Drug Class Focused Reviews</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5648691</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5648691</guid>        </item>
        <item>
            <title>State-Specific Prevalence of No Leisure-Time Physical Activity Among Adults With and Without Doctor-Diagnosed Arthritis--United States, 2009 [From the Centers for Disease Control and Prevention]</title>
            <link>http://www.medworm.com/index.php?rid=5649622&amp;cid=c_12_22_f&amp;fid=30433&amp;url=http%3A%2F%2Fjama.ama-assn.org%2Fcgi%2Fcontent%2Fshort%2F307%2F5%2F447%3Frss%3D1</link>
            <description>(Source: JAMA)</description>
            <author>JAMA</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5649622</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5649622</guid>        </item>
        <item>
            <title>JAK2 and STAT3 Polymorphisms in a Han Chinese Population with Behcet's Disease [Genetics]</title>
            <link>http://www.medworm.com/index.php?rid=5650834&amp;cid=c_12_30_f&amp;fid=32299&amp;url=http%3A%2F%2Fwww.iovs.org%2Fcgi%2Fcontent%2Ffull%2F53%2F1%2F538%3Frss%3D1</link>
            <description>Conclusions.
These results suggest that a STAT3 genetic polymorphism is associated with the susceptibility to BD. (Source: Investigative Ophthalmology)</description>
            <author>Investigative Ophthalmology</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5650834</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5650834</guid>        </item>
        <item>
            <title>Improved dynamic response assessment for intra‐articular injected iron oxide nanoparticles</title>
            <link>http://www.medworm.com/index.php?rid=5651967&amp;cid=c_12_37_f&amp;fid=33601&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fmrm.24166</link>
            <description>AbstractThe emerging importance of nanoparticle technology, including iron oxide nanoparticles for monitoring development, progression, and treatment of inflammatory diseases such as arthritis, drives development of imaging techniques. Studies require an imaging protocol that is sensitive and quantifiable for the detection of iron oxide over a wide range of concentrations. Conventional signal loss measurements of iron oxide nanoparticle containing tissues saturate at medium concentrations and show a nonlinear/nonproportional intensity to concentration profile due to the competing effects of T1 and T2 relaxation. A concentration calibration phantom and an in vivo study of intra‐articular injection in a rat knee of known concentrations of iron oxide were assessed using the difference‐ult...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Magnetic Resonance in Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5651967</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5651967</guid>        </item>
        <item>
            <title>Gene silencing of IL-12 in dendritic cells inhibits autoimmune arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5652396&amp;cid=c_12_39_f&amp;fid=32101&amp;url=http%3A%2F%2Fwww.translational-medicine.com%2Fcontent%2F10%2F1%2F19</link>
            <description>Conclusion:
We demonstrate a novel tolerance-inducing protocol for the treatment of autoimmune inflammatory joint disease in which the target antigen is known, utilizing DNA-directed RNA interference. (Source: Journal of Translational Medicine)</description>
            <author>Journal of Translational Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5652396</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5652396</guid>        </item>
        <item>
            <title>Therapy of lupus nephritis: lessons learned from clinical research and daily care to patients</title>
            <link>http://www.medworm.com/index.php?rid=5653764&amp;cid=c_12_41_f&amp;fid=29968&amp;url=http%3A%2F%2Farthritis-research.com%2Fcontent%2F14%2F1%2F202</link>
            <description>Despite numerous randomized clinical trials over the last three decades for identifying the optimal treatment option for lupus nephritis, renal involvement still significantly impacts the survival and quality of life of patients with lupus and the search for the ideal immunosuppressive regimen is far from complete. The purpose of this review is to summarize the major recent achievements in the field. More specifically, the following topics will be discussed: intravenous cyclophosphamide versus mycophenolate mofetil (MMF) for induction; azathioprine versus MMF for maintenance; targeted therapies. The review will address clues for optimal global care, such as the need for complete initial evaluation, the importance of patient education, the unmasking of non-compliance to therapy, the reason ...</description>
            <author>Arthritis Research and Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653764</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653764</guid>        </item>
        <item>
            <title>A profile of immune response to herpesvirus is associated with radiographic damage in rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5653765&amp;cid=c_12_41_f&amp;fid=29968&amp;url=http%3A%2F%2Farthritis-research.com%2Fcontent%2F14%2F1%2FR24</link>
            <description>Conclusions:
A profile of immune response to purified CMV/EBV lysates is associated with radiographic joint damage. The correlation of this immune response to CMV serology implies possible involvement of latent CMV infection. Therefore, the findings suggest that the immune response to latent CMV infection could play a fundamental role in the progression of inflammation and structural joint damage in patients with RA. (Source: Arthritis Research and Therapy)</description>
            <author>Arthritis Research and Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653765</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653765</guid>        </item>
        <item>
            <title>New evidence for the role of proteasome inhibitors in systemic lupus erythematosus</title>
            <link>http://www.medworm.com/index.php?rid=5653786&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.34407</link>
            <description>(Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653786</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653786</guid>        </item>
        <item>
            <title>Could the “Cochin risk prediction score” be applied in daily practice to predict pulmonary hypertension in systemic sclerosis?</title>
            <link>http://www.medworm.com/index.php?rid=5653787&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.34408</link>
            <description>(Source: Arthritis and Rheumatism)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653787</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653787</guid>        </item>
        <item>
            <title>Sustained response and prevention of damage progression in patients with neonatal‐onset multisystem inflammatory disease (NOMID) treated with anakinra</title>
            <link>http://www.medworm.com/index.php?rid=5653788&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.34409</link>
            <description>Conclusion:Anakinra provides sustained efficacy in the treatment of NOMID for up to five years, with the requirement of dose escalation. Damage progression in the CNS, ear, and eye – but not bone – is preventable. Anakinra is overall well tolerated. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653788</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653788</guid>        </item>
        <item>
            <title>Juvenile‐onset SLE; disease activity, severity and damage ‐ the UK JSLE Cohort Study</title>
            <link>http://www.medworm.com/index.php?rid=5653789&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.34410</link>
            <description>ConclusionThe UK JSLE Cohort Study, one of the largest national JSLE inception cohorts to date, has demonstrated severe organ involvement and significant disease activity. Damage accumulation is also seen. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653789</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653789</guid>        </item>
        <item>
            <title>Dual regulation of metalloproteinase expression in chondrocytes by WISP3/CCN6</title>
            <link>http://www.medworm.com/index.php?rid=5653790&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.34411</link>
            <description>ConclusionWISP3/CCN6 was highly expressed in end‐stage osteoarthritic cartilage suggesting a role for this growth factor in cartilage homeostasis. WISP3/CCN6 repression of ADAMTS5 expression and regulation of MMP10 expression suggests complex and context‐dependent roles for WISP3/CCN6 in cartilage biology. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653790</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653790</guid>        </item>
        <item>
            <title>Decreased intrinsic brain connectivity is associated with reduced clinical pain in fibromyalgia</title>
            <link>http://www.medworm.com/index.php?rid=5653791&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.34412</link>
            <description>CONCLUSIONS:Our findings suggest that intrinsic brain connectivity can be used as a candidate objective marker that tracks intra‐subject with changes in spontaneous chronic pain in FM. We propose that intrinsic connectivity measures could potentially be used either in research or clinical settings as a complementary, more objective outcome. © 2012 American College of Rheumatology. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653791</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653791</guid>        </item>
        <item>
            <title>Transverse acroosteolysis</title>
            <link>http://www.medworm.com/index.php?rid=5653792&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.34413</link>
            <description>(Source: Arthritis and Rheumatism)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653792</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653792</guid>        </item>
        <item>
            <title>Inflammatory regulation of glucocorticoid metabolism in mesenchymal stromal cells</title>
            <link>http://www.medworm.com/index.php?rid=5653793&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.34414</link>
            <description>Conclusion:The mechanism by which stromal cell expression of 11β‐HSD1 is regulated is novel and distinct from that in other tissues. These findings open up new opportunities to inhibit or stimulate local glucocorticoid levels in cells of mesenchymal stromal lineage during inflammation. © 2012 American College of Rheumatology. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653793</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653793</guid>        </item>
        <item>
            <title>Scaffold protein Disc large homolog 1 is required for T-cell receptor-induced activation of regulatory T-cell function [Immunology]</title>
            <link>http://www.medworm.com/index.php?rid=5655260&amp;cid=c_12_58_f&amp;fid=30174&amp;url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F109%2F5%2F1625.short%3Frss%3D1</link>
            <description>Foxp3+CD4+CD25high regulatory T cell (Treg) suppression of inflammation depends on T-cell receptor-mediated Nuclear Factor of Activated T cells c1 (NFATc1) activation with reduced Akt activity. We investigated the role of the scaffold protein Disc large homolog 1 (Dlgh1) in linking the T-cell receptor to this unique signaling outcome. The Treg immunological synapse (IS) recruited fourfold more Dlgh1 than conventional CD4+ T-cell IS. Tregs isolated from patients with active rheumatoid arthritis, or treated with tumor necrosis factor-α, displayed reduced function and diminished Dlgh1 recruitment to the IS. Furthermore, Dlgh1 silencing abrogated Treg function, impaired NFATc1 activation, reduced phosphatase and tensin homolog levels, and increased Akt activation. Dlgh1 operates independently...</description>
            <author>Proceedings of the National Academy of Sciences</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5655260</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5655260</guid>        </item>
        <item>
            <title>IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G [Medical Sciences]</title>
            <link>http://www.medworm.com/index.php?rid=5655268&amp;cid=c_12_58_f&amp;fid=30174&amp;url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F109%2F5%2F1673.short%3Frss%3D1</link>
            <description>Interleukin-33 (IL-33) (NF-HEV) is a chromatin-associated nuclear cytokine from the IL-1 family, which has been linked to important diseases, including asthma, rheumatoid arthritis, ulcerative colitis, and cardiovascular diseases. IL-33 signals through the ST2 receptor and drives cytokine production in type 2 innate lymphoid cells (ILCs) (natural helper cells, nuocytes), T-helper (Th)2 lymphocytes, mast cells, basophils, eosinophils, invariant natural killer T (iNKT), and natural killer (NK) cells. We and others recently reported that, unlike IL-1β and IL-18, full-length IL-33 is biologically active independently of caspase-1 cleavage and that processing by caspases results in IL-33 inactivation. We suggested that IL-33, which is released upon cellular damage, may function as an endogenou...</description>
            <author>Proceedings of the National Academy of Sciences</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5655268</comments>
            <pubDate>Tue, 31 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5655268</guid>        </item>
        <item>
            <title>Effect of Biotherapies on Fatigue in Rheumatoid ArthritisEffect of Biotherapies on Fatigue in Rheumatoid Arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5643665&amp;cid=c_12_26_f&amp;fid=36062&amp;url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F756301%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F756301%3Fsrc%3Drss</link>
            <description>Do biotherapies cause fatigue in rheumatoid arthritis patients?  Rheumatology (Source: Medscape Today Headlines)</description>
            <author>Medscape Today Headlines</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643665</comments>
            <pubDate>Tue, 31 Jan 2012 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5643665</guid>        </item>
        <item>
            <title>Whether they creak, throb, lock or swell up there's a fix for every type of faulty knee</title>
            <link>http://www.medworm.com/index.php?rid=5650260&amp;cid=c_12_26_f&amp;fid=23269&amp;url=http%3A%2F%2Fwww.dailymail.co.uk%2Fhealth%2Farticle-2093983%2FWhether-creak-throb-lock-swell-theres-fix-type-faulty-knee.html%3FITO%3D1490</link>
            <description>Arthritis isn&amp;#8217;t the only cause of pain. Here, we look at common knee problems &amp;#8212; and what you can do about them. (Source: the Mail online | Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>the Mail online | Health</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5650260</comments>
            <pubDate>Mon, 30 Jan 2012 22:49:13 +0100</pubDate>
            <guid isPermaLink="false">5650260</guid>        </item>
        <item>
            <title>Osteoarthritis and the inflammatory arthritides</title>
            <link>http://www.medworm.com/index.php?rid=5641651&amp;cid=c_12_43_f&amp;fid=38670&amp;url=http%3A%2F%2Fwww.surgeryjournal.co.uk%2Farticle%2FPIIS0263931911002481%2Fabstract%3Frss%3Dyes</link>
            <description>This article aims to provide surgeons with a practical, clinical overview of different forms of ‘arthritis’ – a term encompassing most of the joint pathology causing joint symptoms or dysfunction. Conventionally, arthritis can be non-inflammatory (osteoarthritis) or inflammatory (crystal and autoimmune arthropathies). Septic arthritis is an important differential diagnosis when patients present with tender, swollen joints, but is not covered here. Common symptoms and signs in patients with different types of arthritis are reviewed, as well as aetiology and pathogenesis. Non-surgical treatment is described, with particular reference to the inflammatory arthropathies since the new, effective biologic treatments are particularly important where surgery is planned or patients present wit...</description>
            <author>Surgery (Medicine Publishing)</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641651</comments>
            <pubDate>Mon, 30 Jan 2012 14:21:38 +0100</pubDate>
            <guid isPermaLink="false">5641651</guid>        </item>
        <item>
            <title>ACR Announcements</title>
            <link>http://www.medworm.com/index.php?rid=5641548&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.34357</link>
            <description>(Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641548</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:40 +0100</pubDate>
            <guid isPermaLink="false">5641548</guid>        </item>
        <item>
            <title>Reply</title>
            <link>http://www.medworm.com/index.php?rid=5641547&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33405</link>
            <description>(Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641547</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:39 +0100</pubDate>
            <guid isPermaLink="false">5641547</guid>        </item>
        <item>
            <title>The intestinal microbiome in ankylosing spondylitis: Comment on the article by Rosenbaum and Davey</title>
            <link>http://www.medworm.com/index.php?rid=5641546&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33406</link>
            <description>(Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641546</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:38 +0100</pubDate>
            <guid isPermaLink="false">5641546</guid>        </item>
        <item>
            <title>Reply</title>
            <link>http://www.medworm.com/index.php?rid=5641545&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33427</link>
            <description>(Source: Arthritis and Rheumatism)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641545</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:36 +0100</pubDate>
            <guid isPermaLink="false">5641545</guid>        </item>
        <item>
            <title>Alternative explanations for development of late‐onset neutropenia in rituximab‐treated rheumatic disease patients: Comment on the article by Tesfa et al</title>
            <link>http://www.medworm.com/index.php?rid=5641544&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33428</link>
            <description>(Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641544</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:35 +0100</pubDate>
            <guid isPermaLink="false">5641544</guid>        </item>
        <item>
            <title>Intraarticular soluble interleukin‐17 receptor levels are increased in patients with rheumatoid arthritis and correlate with local mediators of inflammation: Comment on the article by Pickens et al</title>
            <link>http://www.medworm.com/index.php?rid=5641543&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33373</link>
            <description>(Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641543</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:32 +0100</pubDate>
            <guid isPermaLink="false">5641543</guid>        </item>
        <item>
            <title>Clinical images: Infarct‐associated bone sarcoma in the clinical context of systemic lupus erythematosus</title>
            <link>http://www.medworm.com/index.php?rid=5641542&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33421</link>
            <description>(Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641542</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:31 +0100</pubDate>
            <guid isPermaLink="false">5641542</guid>        </item>
        <item>
            <title>Reduced insular γ‐aminobutyric acid in fibromyalgia</title>
            <link>http://www.medworm.com/index.php?rid=5641541&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33339</link>
            <description>ConclusionDiminished inhibitory neurotransmission resulting from lower concentrations of GABA within the right anterior insula may play a role in the pathophysiology of FM and other central pain syndromes. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641541</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:29 +0100</pubDate>
            <guid isPermaLink="false">5641541</guid>        </item>
        <item>
            <title>Defective DNA double‐strand break repair in pediatric systemic lupus erythematosus</title>
            <link>http://www.medworm.com/index.php?rid=5641540&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33334</link>
            <description>ConclusionOur data suggest that DSB repair is defective in some lymphoblastoid cell lines from pediatric patients with SLE, especially when assessed by both NCA and CSA. Since these studies are nonspecific, further studies of DNA repair and kinetics are indicated to further delineate the underlying pathogenesis of SLE and possibly identify therapeutic targets. (Source: Arthritis and Rheumatism)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641540</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:27 +0100</pubDate>
            <guid isPermaLink="false">5641540</guid>        </item>
        <item>
            <title>A phase II, multicenter, open‐label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features</title>
            <link>http://www.medworm.com/index.php?rid=5641539&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33342</link>
            <description>ConclusionCanakinumab has a promising preliminary safety and efficacy profile in this limited cohort. Based on the findings of this trial, further studies in a larger population of children with systemic JIA are warranted. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641539</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:26 +0100</pubDate>
            <guid isPermaLink="false">5641539</guid>        </item>
        <item>
            <title>Small‐vessel vasculitis surrounding an uninflamed temporal artery and isolated vasa vasorum vasculitis of the temporal artery: Two subsets of giant cell arteritis</title>
            <link>http://www.medworm.com/index.php?rid=5641538&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33362</link>
            <description>ConclusionOur findings indicate that isolated VVV and SVV should be considered part of the histopathologic spectrum of GCA. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641538</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:25 +0100</pubDate>
            <guid isPermaLink="false">5641538</guid>        </item>
        <item>
            <title>Risk factors for relapse of antineutrophil cytoplasmic antibody–associated vasculitis</title>
            <link>http://www.medworm.com/index.php?rid=5641537&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33361</link>
            <description>ConclusionRelapse of disease is common for patients with AAV. A creatinine level &amp;gt;200 μmoles/liter at the time of diagnosis is strongly associated with a reduced risk of relapse and may help guide monitoring and treatment of patients with AAV. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641537</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:24 +0100</pubDate>
            <guid isPermaLink="false">5641537</guid>        </item>
        <item>
            <title>Clinical images: Steroid‐induced chemical synovitis</title>
            <link>http://www.medworm.com/index.php?rid=5641536&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33429</link>
            <description>(Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641536</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:22 +0100</pubDate>
            <guid isPermaLink="false">5641536</guid>        </item>
        <item>
            <title>Immature muscle precursors are a source of interferon‐β in myositis: Role of Toll‐like receptor 3 activation and contribution to HLA class I up‐regulation</title>
            <link>http://www.medworm.com/index.php?rid=5641535&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33350</link>
            <description>ConclusionImmature muscle precursors may represent a local source of IFNβ and the target of an immune response involving activated DCs associated with the expression of CLRs and of IL‐12 and IL‐23, which are implicated in T cell polarization. In turn, such local production of IFNβ after TLR‐3 activation in the presence of the Th1 cytokine IFNγ may explain HLA class I overexpression in myositis. (Source: Arthritis and Rheumatism)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641535</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:21 +0100</pubDate>
            <guid isPermaLink="false">5641535</guid>        </item>
        <item>
            <title>Myositis‐specific anti‐155/140 autoantibodies target transcription intermediary factor 1 family proteins</title>
            <link>http://www.medworm.com/index.php?rid=5641534&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33403</link>
            <description>ConclusionAnti‐155/140 antibodies target TIF‐1 family proteins, TIF‐1α and TIF‐1β, in addition to TIF‐1γ. Since TIF‐1 proteins have significant roles in oncogenesis, these antibodies may be produced during misdirected antitumor immunity. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641534</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:18 +0100</pubDate>
            <guid isPermaLink="false">5641534</guid>        </item>
        <item>
            <title>Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events</title>
            <link>http://www.medworm.com/index.php?rid=5641533&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33340</link>
            <description>ConclusionThe aPL‐S is a useful quantitative index for diagnosing APS and may be a predictive marker for thrombosis in autoimmune diseases. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641533</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:17 +0100</pubDate>
            <guid isPermaLink="false">5641533</guid>        </item>
        <item>
            <title>Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody‐secreting cells</title>
            <link>http://www.medworm.com/index.php?rid=5641532&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33333</link>
            <description>ConclusionInhibition of the immunoproteasome is equally efficacious as dual targeting agents in preventing lupus disease progression by targeting 2 critical pathways in disease pathogenesis, type I IFN activation and autoantibody production by plasma cells. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641532</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:16 +0100</pubDate>
            <guid isPermaLink="false">5641532</guid>        </item>
        <item>
            <title>Evidence for gene–gene epistatic interactions among susceptibility loci for systemic lupus erythematosus</title>
            <link>http://www.medworm.com/index.php?rid=5641531&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33354</link>
            <description>ConclusionWe provide evidence for gene–gene epistasis in systemic lupus erythematosus. These findings support a role for genetic interaction contributing to the complexity of lupus heritability. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641531</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:15 +0100</pubDate>
            <guid isPermaLink="false">5641531</guid>        </item>
        <item>
            <title>NLRP3 inflammasome–mediated neutrophil recruitment and hypernociception depend on leukotriene B4 in a murine model of gout</title>
            <link>http://www.medworm.com/index.php?rid=5641530&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33355</link>
            <description>ConclusionThese results reveal the role of the NLRP3 inflammasome in mediating MSU crystal–induced inflammation and dysfunction of the joints, and highlight a previously unrecognized role of LTB4 in driving NLRP3 inflammasome activation in response to MSU crystals, both in vitro and in vivo. (Source: Arthritis and Rheumatism)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641530</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:13 +0100</pubDate>
            <guid isPermaLink="false">5641530</guid>        </item>
        <item>
            <title>Clinical images: Synovial fluid clues to ochronosis</title>
            <link>http://www.medworm.com/index.php?rid=5641529&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33409</link>
            <description>(Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641529</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:12 +0100</pubDate>
            <guid isPermaLink="false">5641529</guid>        </item>
        <item>
            <title>Cyclic loading increases friction and changes cartilage surface integrity in lubricin‐mutant mouse knees</title>
            <link>http://www.medworm.com/index.php?rid=5641528&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33337</link>
            <description>ConclusionOur findings indicate that mice lacking lubricin have increased baseline coefficient of friction values and are not protected against further increases caused by loading. Prg4+/− mice are indistinguishable from Prg4+/+ mice at baseline, but have significantly greater coefficient of friction values following 26 hours of loading. Lubricin dosage affects joint properties during loading, and may have clinical implications in patients for whom injury or illness alters lubricin abundance. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641528</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:11 +0100</pubDate>
            <guid isPermaLink="false">5641528</guid>        </item>
        <item>
            <title>Osteoarthritic change is delayed in a Ctsk‐knockout mouse model of osteoarthritis</title>
            <link>http://www.medworm.com/index.php?rid=5641527&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33398</link>
            <description>ConclusionThese results indicate that CTK plays crucial direct roles in the early to intermediate stage of OA development. CTK‐positive chondrocytes and synovial cells may be a possible target to prevent disease progression in OA. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641527</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:09 +0100</pubDate>
            <guid isPermaLink="false">5641527</guid>        </item>
        <item>
            <title>Induction of osteoarthritis and metabolic inflammation by a very high‐fat diet in mice: Effects of short‐term exercise</title>
            <link>http://www.medworm.com/index.php?rid=5641526&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33332</link>
            <description>ConclusionObesity induced by a very high‐fat diet in mice causes OA and systemic inflammation in proportion to body fat. Increased joint loading is not sufficient to explain the increased incidence of knee OA with obesity, as wheel running is protective rather than damaging. Exercise improves glucose tolerance and disrupts the coexpression of proinflammatory cytokines, suggesting that increased aerobic exercise may act independently of weight loss in promoting joint health. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641526</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:08 +0100</pubDate>
            <guid isPermaLink="false">5641526</guid>        </item>
        <item>
            <title>Prevalence of magnetic resonance imaging–defined atrophic and hypertrophic phenotypes of knee osteoarthritis in a population‐based cohort</title>
            <link>http://www.medworm.com/index.php?rid=5641525&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33344</link>
            <description>ConclusionThe majority of knees with severe tibiofemoral cartilage damage exhibited moderate to large osteophytes. The larger the osteophyte, the more likely was the presence of severe cartilage damage. A minority of knees exhibited the atrophic phenotype, which also included knees without radiographic OA. The hypertrophic phenotype was extremely rare. (Source: Arthritis and Rheumatism)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641525</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:05 +0100</pubDate>
            <guid isPermaLink="false">5641525</guid>        </item>
        <item>
            <title>The incidence of knee arthroplasty for primary osteoarthritis grows rapidly among baby boomers: A population‐based study in Finland</title>
            <link>http://www.medworm.com/index.php?rid=5641524&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33367</link>
            <description>ConclusionWe demonstrated a rapid increase in the incidence of arthroplasty among patients with primary knee OA in Finland, especially in those ages 50–59 years. There was no single explanatory factor behind this finding, although some of the growth might be due to the increased incidence noted in low‐ and intermediate‐volume hospitals. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641524</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:04 +0100</pubDate>
            <guid isPermaLink="false">5641524</guid>        </item>
        <item>
            <title>Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3–selective inhibitor reduces interleukin‐6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients</title>
            <link>http://www.medworm.com/index.php?rid=5641523&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33382</link>
            <description>ConclusionHDAC activity is dysregulated in RA PBMCs and is a potential target for therapeutic intervention, as it is not affected by conventional anti‐TNF treatment with etanercept. Both the selective and the nonselective HDAC inhibitors (MI192 and TSA, respectively) were found to regulate cytokine production from PBMCs, but their effects were cell type and compound specific. HDAC inhibitors have potential in the treatment of RA, and HDAC‐selective inhibition may improve the therapeutic margin of safety; however, further clinical characterization and evaluation for adverse effects is needed. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641523</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:03 +0100</pubDate>
            <guid isPermaLink="false">5641523</guid>        </item>
        <item>
            <title>CXCL12γ isoform is expressed on endothelial and dendritic cells in rheumatoid arthritis synovium and regulates T cell activation</title>
            <link>http://www.medworm.com/index.php?rid=5641522&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33345</link>
            <description>ConclusionCXCL12γ shows a specific and similar distribution in RA synovium and lymphoid tissue, consistent with its higher HS binding affinity. Presentation of CXCL12 to T cells on membrane HS in DCs can play a distinct regulatory role in T cell activation. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641522</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:02 +0100</pubDate>
            <guid isPermaLink="false">5641522</guid>        </item>
        <item>
            <title>Interferon signals and monocytic sensitization of the interferon‐γ signaling pathway in the peripheral blood of patients with rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5641521&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33347</link>
            <description>ConclusionIn addition to supporting the role of IFNs in systemic proinflammatory activity, the results of this study further suggest preactivation of the IFNγ/STAT‐1 signaling pathway, especially in RA monocytes. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641521</comments>
            <pubDate>Mon, 30 Jan 2012 13:25:00 +0100</pubDate>
            <guid isPermaLink="false">5641521</guid>        </item>
        <item>
            <title>Molecular imaging of cartilage damage of finger joints in early rheumatoid arthritis with delayed gadolinium‐enhanced magnetic resonance imaging</title>
            <link>http://www.medworm.com/index.php?rid=5641520&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33352</link>
            <description>ConclusionOur findings indicate that cartilage damage is present in the MCP joints of patients with early RA despite the absence of joint space narrowing on standard radiographs and MRI. Cartilage damage in RA can be imaged with dGEMRIC. (Source: Arthritis and Rheumatism)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641520</comments>
            <pubDate>Mon, 30 Jan 2012 13:24:59 +0100</pubDate>
            <guid isPermaLink="false">5641520</guid>        </item>
        <item>
            <title>The clinical picture of rheumatoid arthritis according to the 2010 American College of Rheumatology/European League Against Rheumatism criteria: Is this still the same disease?</title>
            <link>http://www.medworm.com/index.php?rid=5641519&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33348</link>
            <description>ConclusionUse of the 2010 ACR/EULAR criteria clearly allows earlier diagnosis of RA, although the clinical picture is slightly different on the group level, and RA may be falsely diagnosed in some patients with self‐limiting disease. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641519</comments>
            <pubDate>Mon, 30 Jan 2012 13:24:57 +0100</pubDate>
            <guid isPermaLink="false">5641519</guid>        </item>
        <item>
            <title>Microchimerism in the rheumatoid nodules of patients with rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5641518&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33358</link>
            <description>ConclusionOur findings indicate that microchimerism is frequently present in the rheumatoid nodules of RA patients. Since microchimerism is genetically disparate, whether microchimerism in rheumatoid nodules serves as an allogeneic stimulus or allogeneic target warrants further investigation. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641518</comments>
            <pubDate>Mon, 30 Jan 2012 13:24:56 +0100</pubDate>
            <guid isPermaLink="false">5641518</guid>        </item>
        <item>
            <title>Structural changes of the brain in rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5641517&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33326</link>
            <description>ConclusionOur results suggest that RA is associated with changes in the subcortical gray matter rather than with cortical gray matter atrophy. Since the basal ganglia play an important role in motor control as well as in pain processing and in modulating behavior in response to aversive stimuli, we suggest that these changes may result from altered motor control or prolonged pain processing. The differences in brain volume may reflect either generalized atrophy or differences in brain development. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641517</comments>
            <pubDate>Mon, 30 Jan 2012 13:24:55 +0100</pubDate>
            <guid isPermaLink="false">5641517</guid>        </item>
        <item>
            <title>Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: Results of a forty‐eight–week randomized, double‐blind, placebo‐controlled, parallel‐group phase III trial</title>
            <link>http://www.medworm.com/index.php?rid=5641516&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33353</link>
            <description>ConclusionPatients in both of the ocrelizumab groups met the clinical primary efficacy end points. Inhibition of change in the SHS was statistically significant at 48 weeks for those in the ocrelizumab 500 mg group. The rate of serious infections in this trial was higher for both ocrelizumab doses as compared with placebo. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641516</comments>
            <pubDate>Mon, 30 Jan 2012 13:24:53 +0100</pubDate>
            <guid isPermaLink="false">5641516</guid>        </item>
        <item>
            <title>Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a forty‐eight–week randomized, double‐blind, placebo‐controlled, parallel‐group phase III trial</title>
            <link>http://www.medworm.com/index.php?rid=5641515&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33317</link>
            <description>ConclusionWith both ocrelizumab doses, the primary end point was met, and the signs and symptoms of RA were significantly improved at weeks 24 and 48. Ocrelizumab also significantly inhibited the progression of joint damage. A higher rate of serious infections was observed with 500 mg of ocrelizumab as compared with ocrelizumab 200 mg or placebo. (Source: Arthritis and Rheumatism)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641515</comments>
            <pubDate>Mon, 30 Jan 2012 13:24:52 +0100</pubDate>
            <guid isPermaLink="false">5641515</guid>        </item>
        <item>
            <title>Autoantibodies to transcription intermediary factor 1 in dermatomyositis shed insight into the cancer–myositis connection</title>
            <link>http://www.medworm.com/index.php?rid=5641514&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33402</link>
            <description>(Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641514</comments>
            <pubDate>Mon, 30 Jan 2012 13:24:50 +0100</pubDate>
            <guid isPermaLink="false">5641514</guid>        </item>
        <item>
            <title>Beyond the “syndrome”: Antiphospholipid antibodies as risk factors</title>
            <link>http://www.medworm.com/index.php?rid=5641513&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33341</link>
            <description>(Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641513</comments>
            <pubDate>Mon, 30 Jan 2012 13:24:49 +0100</pubDate>
            <guid isPermaLink="false">5641513</guid>        </item>
        <item>
            <title>In this issue</title>
            <link>http://www.medworm.com/index.php?rid=5641512&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.34358</link>
            <description>(Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641512</comments>
            <pubDate>Mon, 30 Jan 2012 13:24:45 +0100</pubDate>
            <guid isPermaLink="false">5641512</guid>        </item>
        <item>
            <title>The association of lumbar intervertebral disc degeneration on MRI in overweight and obese adults: A population‐based study</title>
            <link>http://www.medworm.com/index.php?rid=5641511&amp;cid=c_12_41_f&amp;fid=33586&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fart.33462</link>
            <description>Conclusions:In one of the largest studies to systematically assess lumbar disc degeneration on MRI, our study noted a significant association between the presence, increased extent, and global severity of disc degeneration in overweight and obese adults. (Source: Arthritis and Rheumatism)</description>
            <author>Arthritis and Rheumatism</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641511</comments>
            <pubDate>Mon, 30 Jan 2012 13:20:31 +0100</pubDate>
            <guid isPermaLink="false">5641511</guid>        </item>
        <item>
            <title>Lumbar disc degeneration more likely in overweight and obese adults</title>
            <link>http://www.medworm.com/index.php?rid=5639813&amp;cid=c_12_46_f&amp;fid=31011&amp;url=http%3A%2F%2Fwww.eurekalert.org%2Fpub_releases%2F2012-01%2Fw-ldd012512.php</link>
            <description>(Wiley-Blackwell) One of the largest studies to investigate lumbar spine disc degeneration found that adults who are overweight or obese were significantly more likely to have disc degeneration than those with a normal body mass index. Details of this study now appear in Arthritis &amp; Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology. (Source: EurekAlert! - Medicine and Health)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>EurekAlert! - Medicine and Health</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639813</comments>
            <pubDate>Mon, 30 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5639813</guid>        </item>
        <item>
            <title>Evaluation of finger joint synovial vascularity in patients with rheumatoid arthritis using contrast‐enhanced ultrasound with water immersion and a stabilized probe</title>
            <link>http://www.medworm.com/index.php?rid=5640130&amp;cid=c_12_37_f&amp;fid=33645&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fjcu.21887</link>
            <description>Conclusions.CEUS with a fixed probe on finger joints immersed in water detected synovial vascularization in RA, producing results suitable for standardized software analysis and avoiding artifacts. © 2012 Wiley Periodicals, Inc. J Clin Ultrasound, 2012 (Source: Journal of Clinical Ultrasound)</description>
            <author>Journal of Clinical Ultrasound</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5640130</comments>
            <pubDate>Mon, 30 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5640130</guid>        </item>
        <item>
            <title>Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis?</title>
            <link>http://www.medworm.com/index.php?rid=5641494&amp;cid=c_12_41_f&amp;fid=29968&amp;url=http%3A%2F%2Farthritis-research.com%2Fcontent%2F14%2F1%2F201</link>
            <description>Glucosamine in its acetylated form is a natural constituent of some glycosaminoglycans (e.g. hyaluronic acid and keratan sulfate) in the proteoglycans found in articular cartilage, intervertebral disc and synovial fluid. Glucosamine can be extracted and stabilized by chemical modification and used as a drug or a nutraceutical. It has been approved for the treatment of osteoarthritis (OA) in Europe to promote cartilage and joint health and is sold over the counter as a dietary supplement in the United States. Various formulations of glucosamine have been tested including glucosamine sulfate and glucosamine hydrochloride. In vitro and in vivo studies have uncovered glucosamine's mechanisms of action on articular tissues (cartilage, synovial membrane and subchondral bone) and justified its ef...</description>
            <author>Arthritis Research and Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641494</comments>
            <pubDate>Mon, 30 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5641494</guid>        </item>
        <item>
            <title>Confirmation of association of FCGR3B but not FCGR3A copy number with susceptibility to autoantibody positive rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5642447&amp;cid=c_12_50_f&amp;fid=33774&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Fhumu.22031</link>
            <description>AbstractThe FCGR locus encoding the low‐affinity Fcγ receptors for IgG has largely been missed by genome‐wide association studies due to complications with structural variation and segmental duplication. Recently identified CNVs affecting FCGR3A and FCGR3B have been linked to a number of autoimmune disorders. We have developed and validated a novel quantitative sequence variant (QSV) assay in combination with an adapted paralogue ratio test to examine independent CNVs carrying FCGR3A and FCGR3B in rheumatoid arthritis (RA) compared with healthy controls (n=1115 and 654, respectively). Implementation of a robust statistical analysis framework (CNVtools) allowed for systematic batch effects and for the inherent uncertainty of copy number assignment, thus avoiding two major sources of fa...</description>
            <author>Human Mutation</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5642447</comments>
            <pubDate>Mon, 30 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5642447</guid>        </item>
        <item>
            <title>Extracellular nicotinamide phosphoribosyltransferase (NAMPT/visfatin) inhibits insulin-like growth factor-1 signaling and proteoglycan synthesis in human articular chondrocytes</title>
            <link>http://www.medworm.com/index.php?rid=5653766&amp;cid=c_12_41_f&amp;fid=29968&amp;url=http%3A%2F%2Farthritis-research.com%2Fcontent%2F14%2F1%2FR23</link>
            <description>Conclusions:
Our study demonstrates that eNAMPT/visfatin inhibits IGF-1 function in articular chondrocytes by activating the ERK/MAPK pathway independent of the IGF-1 receptor. Since eNAMPT levels are elevated in the synovial fluid of OA patients, the signaling pathway activated by eNAMPT could contribute to IGF-1 resistance in OA. (Source: Arthritis Research and Therapy)</description>
            <author>Arthritis Research and Therapy</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653766</comments>
            <pubDate>Mon, 30 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653766</guid>        </item>
        <item>
            <title>Long‐term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus</title>
            <link>http://www.medworm.com/index.php?rid=5653796&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.21624</link>
            <description>Conclusion:This study shows that early neuropsychiatric events due to active SLE are not major contributors to long‐term disease activity, accumulation of damage or health‐related quality‐of‐life. The long‐term prognosis and patterns of disease in SLE patients with early NP events are similar to those of SLE patients without these events. © 2012 by the American College of Rheumatology (Source: Arthritis Care and Research)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653796</comments>
            <pubDate>Mon, 30 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653796</guid>        </item>
        <item>
            <title>Brief fear of movement scale for osteoarthritis</title>
            <link>http://www.medworm.com/index.php?rid=5653797&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.21626</link>
            <description>Conclusion:The brief fear of movement scale identified in this study provides a promising and valid approach for assessing fear of movement in individuals with osteoarthritis. This brief scale demonstrated several important strengths including a small number of items, sound psychometric properties, and consistent performance across diverse groups of individuals with osteoarthritis. © 2012 by the American College of Rheumatology (Source: Arthritis Care and Research)</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653797</comments>
            <pubDate>Mon, 30 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653797</guid>        </item>
        <item>
            <title>A woman with rheumatoid arthritis, Sjögren's syndrome, leg ulcer, and significant weight loss</title>
            <link>http://www.medworm.com/index.php?rid=5653798&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.21628</link>
            <description>(Source: Arthritis Care and Research)</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653798</comments>
            <pubDate>Mon, 30 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653798</guid>        </item>
        <item>
            <title>Consensus treatment plans for new‐onset systemic juvenile idiopathic arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5653799&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.21625</link>
            <description>Conclusion:Four standardized treatment plans were developed for new‐onset sJIA. Coupled with data collection at defined intervals, use of these treatment plans will create the opportunity to evaluate comparative effectiveness in an observational setting to optimize initial management of sJIA. © 2012 by the American College of Rheumatology (Source: Arthritis Care and Research)</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5653799</comments>
            <pubDate>Mon, 30 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5653799</guid>        </item>
        <item>
            <title>Stealthy leprosy pathogen evades critical vitamin D-dependent immune response</title>
            <link>http://www.medworm.com/index.php?rid=5641673&amp;cid=c_12_44_f&amp;fid=38766&amp;url=http%3A%2F%2Fnewsroom.ucla.edu%2Fportal%2Fucla%2Fstealthy-leprosy-pathogen-avoids-218620.aspx%3Flink_page_rss%3D218620</link>
            <description>A team of UCLA scientists has found that the pathogen that causes leprosy has a remarkable ability to avoid the human immune system by inhibiting the antimicrobial responses important to our defenses.
&amp;nbsp;
In one of the first laboratory studies of its kind, researchers discovered that the leprosy pathogen Mycobacterium leprae was able to reduce and evade immune activity that is dependent on vitamin D, a natural hormone that plays an essential role in the body's fight against infections.&amp;nbsp;
&amp;nbsp;
The pathogen manipulated micro-RNAs, tiny molecules made of ribonucleic acids that carry information and that help regulate genes to direct cell activity, including immune system defenses. Micro-RNAs are short RNAs that do not code information for proteins, which carry out all cell activity; ...</description>
            <author>UCLA Newsroom: Health Sciences</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5641673</comments>
            <pubDate>Sun, 29 Jan 2012 18:00:00 +0100</pubDate>
            <guid isPermaLink="false">5641673</guid>        </item>
        <item>
            <title>Kruppel-Like Factor 2 (KLF2) Regulates Monocyte Differentiation and Functions in mBSA and IL-1β-Induced Arthritis.</title>
            <link>http://www.medworm.com/index.php?rid=5637706&amp;cid=c_12_67_f&amp;fid=37012&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22280353%26dopt%3DAbstract</link>
            <description>Authors: Das M, Lu J, Joseph M, Aggarwal R, Kanji S, McMichael BK, Lee BS, Agarwal S, Ray-Chaudhury A, Iwenofu OH, Kuppusamy P, Pompili VJ, Jain MK, Das H
    Abstract
    Kruppel-like factor 2 (KLF2) plays an important role in the regulation of a variety of immune cells, including monocytes. We have previously shown that KLF2 inhibits proinflammatory activation of monocytes. However, the role of KLF2 in arthritis is yet to be investigated. In the current study, we show that recruitment of significantly greater numbers of inflammatory subset of CD11b+F4/80+Ly6C+ monocytes to the inflammatory sites in KLF2 hemizygous mice compared to the wild type littermate controls. In parallel, inflammatory mediators, MCP-1, Cox-2 and PAI-1 were significantly up-regulated in bone marrow-derived monocytes...&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Current Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5637706</comments>
            <pubDate>Sun, 29 Jan 2012 03:19:02 +0100</pubDate>
            <guid isPermaLink="false">5637706</guid>        </item>
        <item>
            <title>HPV Vaccine Not Linked To Autoimmune Disorders, Study</title>
            <link>http://www.medworm.com/index.php?rid=5637692&amp;cid=c_12_26_f&amp;fid=23292&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2FLEdQChe4wRk%2F240897.php</link>
            <description>A two-year study of nearly 190,000 girls and women, finds that Gardasil, the human papillomavirus (HPV) vaccine made by Merck &amp; Co, does not trigger autoimmune disorders such as lupus, rheumatoid arthritis, type 1 diabetes and multiple sclerosis. The results are published in the Journal of Internal Medicine. Study lead author Dr Chun Chao, a research scientist at the Kaiser Permanente Department of Research &amp; Evaluation in Pasadena, California, said in a statement released on Friday, that: &quot;This kind of safety information may help parents with vaccination decisions... (Source: Health News from Medical News Today)</description>
            <author>Health News from Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5637692</comments>
            <pubDate>Sun, 29 Jan 2012 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">5637692</guid>        </item>
        <item>
            <title>In Rheumatoid Arthritis, Steroids Prevent Protein Changes Seen In The Joints</title>
            <link>http://www.medworm.com/index.php?rid=5636311&amp;cid=c_12_26_f&amp;fid=23292&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2FDfXPxAMQCmk%2F240839.php</link>
            <description>Rheumatoid arthritis (RA) is a chronic inflammatory disease where the body begins to attack the joints and organs of the body. Proteins within inflamed joints are often modified by citrullination, a process that converts the protein building block arginine into citrulline. These two amino acids have very different physical properties and consequently conversion can result in aberrant changes in the three-dimensional structure of an affected protein... (Source: Health News from Medical News Today)</description>
            <author>Health News from Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5636311</comments>
            <pubDate>Sat, 28 Jan 2012 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">5636311</guid>        </item>
        <item>
            <title>Prevent Worsening Arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5636617&amp;cid=c_12_164_f&amp;fid=38348&amp;url=http%3A%2F%2Forthopedics.about.com%2Fod%2Farthritistreatment%2Fht%2Fprogression.htm</link>
            <description>Patients diagnosed with early arthritis often worry about needing joint replacement surgery. However, most people with early arthritis can take steps to prevent the progression of their disease. (Source: About.com Eating Disorders)</description>
            <author>About.com Eating Disorders</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5636617</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5636617</guid>        </item>
        <item>
            <title>Steps of a Hip Replacement</title>
            <link>http://www.medworm.com/index.php?rid=5636618&amp;cid=c_12_164_f&amp;fid=38348&amp;url=http%3A%2F%2Forthopedics.about.com%2Fod%2Fhipkneereplacement%2Fss%2Freplacement.htm</link>
            <description>Hip replacement surgery is a treatment for severe arthritis. Hip replacement involves placing a metal and plastic ball and socket in the arthritic joint to substitute for the worn out cartilage. Each step of a hip replacement surgery is explained. (Source: About.com Eating Disorders)</description>
            <author>About.com Eating Disorders</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5636618</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5636618</guid>        </item>
        <item>
            <title>Walking Aids</title>
            <link>http://www.medworm.com/index.php?rid=5636619&amp;cid=c_12_164_f&amp;fid=38348&amp;url=http%3A%2F%2Forthopedics.about.com%2Fod%2Fphysicaltherapy%2Ftp%2Fwalkingaids.htm</link>
            <description>Walking aids are helpful for patients who have chronic problems, including hip and knee arthritis, as well as patients who have acute injuries, including ankle sprains and leg fractures. Finding the right type of walking aid will help you along the way. (Source: About.com Eating Disorders)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>About.com Eating Disorders</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5636619</comments>
            <pubDate>Sat, 28 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5636619</guid>        </item>
        <item>
            <title>Orthopaedic Surgery Rates Declining in Rheumatoid ArthritisOrthopaedic Surgery Rates Declining in Rheumatoid Arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5635966&amp;cid=c_12_26_f&amp;fid=36062&amp;url=http%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F757663%3Fsrc%3Drsshttp%3A%2F%2Fwww.medscape.com%2Fviewarticle%2F757663%3Fsrc%3Drss</link>
            <description>Joint surgery rates have declined since 1980 among patients with rheumatoid arthritis, suggesting that treatment is changing the course of disease.  Medscape Medical News (Source: Medscape Today Headlines)</description>
            <author>Medscape Today Headlines</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5635966</comments>
            <pubDate>Sat, 28 Jan 2012 00:31:26 +0100</pubDate>
            <guid isPermaLink="false">5635966</guid>        </item>
        <item>
            <title>Endstage arthritis following tibia plateau fractures: average 10-year follow up.</title>
            <link>http://www.medworm.com/index.php?rid=5634021&amp;cid=c_12_43_f&amp;fid=32941&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22269220%26dopt%3DAbstract</link>
            <description>Conclusion: Our findings may be used to counsel patients who require surgical treatment of tibia plateau fractures about the long-term risk of requiring reconstructive knee surgery for endstage arthritis in the knee.
    PMID: 22269220 [PubMed - as supplied by publisher] (Source: Canadian Journal of Surgery)</description>
            <author>Canadian Journal of Surgery</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5634021</comments>
            <pubDate>Fri, 27 Jan 2012 16:02:13 +0100</pubDate>
            <guid isPermaLink="false">5634021</guid>        </item>
        <item>
            <title>Too many rheumatoid arthritis patients inactive, study finds</title>
            <link>http://www.medworm.com/index.php?rid=5633958&amp;cid=c_12_26_f&amp;fid=23283&amp;url=http%3A%2F%2Frssfeeds.usatoday.com%2F%7Er%2FUsatodaycomHealth-TopStories%2F%7E3%2FZURNyoiJAfY%2F1</link>
            <description>Experts believe physical activity is important to keep joints flexible, improve balance and strength and reduce pain, the researchers noted. (Source: USATODAY.com Health)</description>
            <author>USATODAY.com Health</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5633958</comments>
            <pubDate>Fri, 27 Jan 2012 14:05:24 +0100</pubDate>
            <guid isPermaLink="false">5633958</guid>        </item>
        <item>
            <title>ARHP announcements</title>
            <link>http://www.medworm.com/index.php?rid=5632986&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.21572</link>
            <description>(Source: Arthritis Care and Research)</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5632986</comments>
            <pubDate>Fri, 27 Jan 2012 10:29:38 +0100</pubDate>
            <guid isPermaLink="false">5632986</guid>        </item>
        <item>
            <title>Unusual case of a swollen painful toe in a young man</title>
            <link>http://www.medworm.com/index.php?rid=5632985&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.20603</link>
            <description>(Source: Arthritis Care and Research)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5632985</comments>
            <pubDate>Fri, 27 Jan 2012 10:29:37 +0100</pubDate>
            <guid isPermaLink="false">5632985</guid>        </item>
        <item>
            <title>Scleroderma digital ulcers complicated by infection with fecal pathogens</title>
            <link>http://www.medworm.com/index.php?rid=5632984&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.20673</link>
            <description>ConclusionA number of effective measures involving health care personnel and hospital environment are essential in the management of digital ulcers and prevention of infectious complications. In addition, the prevalence of fecal pathogens in one‐quarter of cases, never reported previously, suggests an important role of a patient's self‐care limitations, mainly during intercurrent home medications. Consequently, methodical education on hand hygiene of both patients and relatives, frequently involved in ulcer medications, is mandatory to avoid such deleterious complications. (Source: Arthritis Care and Research)</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5632984</comments>
            <pubDate>Fri, 27 Jan 2012 10:29:36 +0100</pubDate>
            <guid isPermaLink="false">5632984</guid>        </item>
        <item>
            <title>Nonsteroidal antiinflammatory drug intake according to the Assessment of SpondyloArthritis International Society Score in clinical trials evaluating tumor necrosis factor blockers: Example of etanercept in advanced ankylosing spondylitis</title>
            <link>http://www.medworm.com/index.php?rid=5632983&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.20671</link>
            <description>ConclusionThis study confirms the feasibility and simplicity of the ASAS‐NSAID score and suggests that such a score be integrated in all studies in spondylarthritis either to check the quality of the observed data (i.e., intergroup baseline characteristics) or to evaluate the NSAID‐sparing effect of other therapies. (Source: Arthritis Care and Research)</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5632983</comments>
            <pubDate>Fri, 27 Jan 2012 10:29:35 +0100</pubDate>
            <guid isPermaLink="false">5632983</guid>        </item>
        <item>
            <title>Self‐management strategies in overweight and obese Canadians with arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5632982&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.20654</link>
            <description>ConclusionFewer than half of the overweight and obese Canadians with arthritis engaged in both weight control/loss and exercise. The provision of targeted clinical recommendations (particularly low in individuals that did not engage in any self‐management strategies) may help to facilitate participation. (Source: Arthritis Care and Research)</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5632982</comments>
            <pubDate>Fri, 27 Jan 2012 10:29:33 +0100</pubDate>
            <guid isPermaLink="false">5632982</guid>        </item>
        <item>
            <title>Assessment of health‐related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's)</title>
            <link>http://www.medworm.com/index.php?rid=5632981&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.20649</link>
            <description>ConclusionHRQOL, as measured by the SF‐36, is reduced among patients with GPA. SF‐36 measures are modestly associated with other disease outcomes and discriminate between disease states of importance in GPA. (Source: Arthritis Care and Research)</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5632981</comments>
            <pubDate>Fri, 27 Jan 2012 10:29:31 +0100</pubDate>
            <guid isPermaLink="false">5632981</guid>        </item>
        <item>
            <title>Rarity of anti–3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase antibodies in statin users, including those with self‐limited musculoskeletal side effects</title>
            <link>http://www.medworm.com/index.php?rid=5632980&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.20662</link>
            <description>ConclusionThe majority of patients with and without statin exposure, including those with self‐limited statin intolerance, do not develop anti‐HMGCR antibodies. Therefore, anti‐HMGCR antibodies are highly specific for those with an autoimmune myopathy. (Source: Arthritis Care and Research)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5632980</comments>
            <pubDate>Fri, 27 Jan 2012 10:29:30 +0100</pubDate>
            <guid isPermaLink="false">5632980</guid>        </item>
        <item>
            <title>Relationship between obesity and foot pain and its association with fat mass, fat distribution, and muscle mass</title>
            <link>http://www.medworm.com/index.php?rid=5632979&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.20663</link>
            <description>ConclusionIncreasing BMI, specifically android fat mass, is strongly associated with foot pain and disability. This may imply both biomechanical and metabolic mechanisms. (Source: Arthritis Care and Research)</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5632979</comments>
            <pubDate>Fri, 27 Jan 2012 10:29:28 +0100</pubDate>
            <guid isPermaLink="false">5632979</guid>        </item>
        <item>
            <title>Women with gout: Efficacy and safety of urate‐lowering with febuxostat and allopurinol</title>
            <link>http://www.medworm.com/index.php?rid=5632978&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.20680</link>
            <description>ConclusionThese data suggest that febuxostat 80 mg may be more efficacious than commonly prescribed doses of allopurinol in female gout subjects with high rates of comorbidities. (Source: Arthritis Care and Research)</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5632978</comments>
            <pubDate>Fri, 27 Jan 2012 10:29:27 +0100</pubDate>
            <guid isPermaLink="false">5632978</guid>        </item>
        <item>
            <title>Association of magnetic resonance imaging–based knee cartilage T2 measurements and focal knee lesions with knee pain: Data from the Osteoarthritis Initiative</title>
            <link>http://www.medworm.com/index.php?rid=5632977&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.20672</link>
            <description>ConclusionThese results suggest that elevated cartilage T2 values are associated with findings of pain in the early phase of OA, whereas among morphologic knee abnormalities only knee cartilage lesions are significantly associated with knee pain status. (Source: Arthritis Care and Research)</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5632977</comments>
            <pubDate>Fri, 27 Jan 2012 10:29:26 +0100</pubDate>
            <guid isPermaLink="false">5632977</guid>        </item>
        <item>
            <title>Long‐term outcomes and costs of an integrated rehabilitation program for chronic knee pain: A pragmatic, cluster randomized, controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=5632976&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.20642</link>
            <description>ConclusionClinical and cost benefits of ESCAPE‐knee pain were still evident 30 months after completing the program. ESCAPE‐knee pain is a more effective and efficient model of care that could substantially improve the health, well‐being, and independence of many people, while reducing health care costs. (Source: Arthritis Care and Research)</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5632976</comments>
            <pubDate>Fri, 27 Jan 2012 10:29:25 +0100</pubDate>
            <guid isPermaLink="false">5632976</guid>        </item>
        <item>
            <title>Diabetes mellitus risk in rheumatoid arthritis: Reduced incidence with anti–tumor necrosis factor α therapy</title>
            <link>http://www.medworm.com/index.php?rid=5632975&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.20657</link>
            <description>ConclusionIn this inception RA cohort, anti‐TNFα use was associated with a 51% reduction in risk of developing diabetes mellitus. (Source: Arthritis Care and Research)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Find the best &lt;a href=&quot;http://www.januarysales.org/&quot; target=&quot;_blank&quot;&gt;January Sales&lt;/a&gt; in the UK.&lt;/p&gt;&lt;/div&gt;</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5632975</comments>
            <pubDate>Fri, 27 Jan 2012 10:29:21 +0100</pubDate>
            <guid isPermaLink="false">5632975</guid>        </item>
        <item>
            <title>Determinants of discordance in patients' and physicians' rating of rheumatoid arthritis disease activity</title>
            <link>http://www.medworm.com/index.php?rid=5632974&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.20685</link>
            <description>ConclusionNearly 36% of patients had discordance in RA activity assessment from their physicians. Sensitivity to the “disease experience” of patients, particularly pain and fatigue, is warranted for effective care of RA. (Source: Arthritis Care and Research)</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5632974</comments>
            <pubDate>Fri, 27 Jan 2012 10:29:20 +0100</pubDate>
            <guid isPermaLink="false">5632974</guid>        </item>
        <item>
            <title>Pain as an important predictor of psychosocial health in patients with rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5632973&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.20652</link>
            <description>ConclusionThis large cohort study demonstrates that pain is the most important predictor of a patient's psychosocial health in RA patients. This suggests that physicians should place greater emphasis on pain management. (Source: Arthritis Care and Research)</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5632973</comments>
            <pubDate>Fri, 27 Jan 2012 10:29:17 +0100</pubDate>
            <guid isPermaLink="false">5632973</guid>        </item>
        <item>
            <title>Work productivity in scleroderma: Analysis from the University of California, Los Angeles scleroderma quality of life study</title>
            <link>http://www.medworm.com/index.php?rid=5632972&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.20676</link>
            <description>ConclusionSSc has a major impact on productivity at home and at work. Nearly 40% of patients reported disability due to their SSc. (Source: Arthritis Care and Research)</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5632972</comments>
            <pubDate>Fri, 27 Jan 2012 10:29:15 +0100</pubDate>
            <guid isPermaLink="false">5632972</guid>        </item>
        <item>
            <title>Longitudinal study of the impact of incident organ manifestations and increased disease activity on work loss among persons with systemic lupus erythematosus</title>
            <link>http://www.medworm.com/index.php?rid=5632971&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.20669</link>
            <description>ConclusionIncident thrombosis and musculoskeletal manifestations, multiple manifestations, and increased disease activity are associated with the risk of work loss in SLE. (Source: Arthritis Care and Research)</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5632971</comments>
            <pubDate>Fri, 27 Jan 2012 10:29:13 +0100</pubDate>
            <guid isPermaLink="false">5632971</guid>        </item>
        <item>
            <title>Systematic review of the epidemiology of systemic lupus erythematosus in the Asia‐Pacific region: Prevalence, incidence, clinical features, and mortality</title>
            <link>http://www.medworm.com/index.php?rid=5632970&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.20683</link>
            <description>ConclusionThis review highlights the need to closely monitor Asian SLE patients in Asian countries for renal and cardiovascular involvement, especially those who may not receive proper treatment and are therefore at greater risk of severe disease. We hope this will encourage further research specific to this region and lead to improved clinical management. (Source: Arthritis Care and Research)&lt;div id=&quot;medworm&quot;&gt;&lt;p&gt;&lt;b&gt;&lt;i&gt;MedWorm Sponsor Message:&lt;/i&gt;&lt;/b&gt; Please support the &lt;a href=&quot;http://www.doctorsinchains.org/&quot; target=&quot;_blank&quot;&gt;Doctors In Chains&lt;/a&gt; campaign for the &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;medics&lt;/a&gt; tortured and sentenced for up to 15 years in &lt;a href=&quot;http://www.doctorsinchains.org/&quot;&gt;Bahrain&lt;/a&gt;. &lt;a href=&quot;https://twitter.com/#!/search/%23FreeDoctors&quot;&gt;#FreeDoctors&lt;/a&gt;&lt;/p&gt;&lt;/div&gt;</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5632970</comments>
            <pubDate>Fri, 27 Jan 2012 10:29:12 +0100</pubDate>
            <guid isPermaLink="false">5632970</guid>        </item>
        <item>
            <title>The public health impact of risk factors for physical inactivity in adults with rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5632966&amp;cid=c_12_41_f&amp;fid=33587&amp;url=http%3A%2F%2Fdx.doi.org%2F10.1002%252Facr.21582</link>
            <description>Conclusion:These results support development of interventions that increase motivation for physical activity and that lead to stronger beliefs related to physical activity's benefits should be considered in public health initiatives to reduce the prevalence of physical inactivity in adults with rheumatoid arthritis. © 2012 by the American College of Rheumatology (Source: Arthritis Care and Research)</description>
            <author>Arthritis Care and Research</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5632966</comments>
            <pubDate>Fri, 27 Jan 2012 10:27:36 +0100</pubDate>
            <guid isPermaLink="false">5632966</guid>        </item>
        <item>
            <title>Nearly half of people with rheumatoid arthritis are inactive despite benefits</title>
            <link>http://www.medworm.com/index.php?rid=5639682&amp;cid=c_12_27_f&amp;fid=38049&amp;url=http%3A%2F%2Fwww.nursingtimes.net%2Fpictures%2F90xAny%2F2%2F3%2F0%2F1243230_arthritis_hand.jpg</link>
            <description>Over 40% of rheumatoid arthritis sufferers are not physically active despite the benefits involved, according to a new study. (Source: Nursing Times Breaking News)</description>
            <author>Nursing Times Breaking News</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5639682</comments>
            <pubDate>Fri, 27 Jan 2012 09:58:00 +0100</pubDate>
            <guid isPermaLink="false">5639682</guid>        </item>
        <item>
            <title>Sedentary Lifestyle A Problem For 2 In 5 Adults With Rheumatoid Arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5633321&amp;cid=c_12_26_f&amp;fid=23292&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2F_Ls2gT2ygT4%2F240825.php</link>
            <description>A new study, funded by a grant from the National Institute for Arthritis and Musculoskeletal and Skin Diseases (NIAMS), found that two in five adults (42%) with rheumatoid arthritis (RA) were inactive. Taking measures to motivate RA patients to increase their physical activity will improve public health according to the findings now available in Arthritis Care &amp; Research, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology (ACR). The ACR estimates nearly 1.3 million adults in the U.S... (Source: Health News from Medical News Today)</description>
            <author>Health News from Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5633321</comments>
            <pubDate>Fri, 27 Jan 2012 09:00:00 +0100</pubDate>
            <guid isPermaLink="false">5633321</guid>        </item>
        <item>
            <title>2-Year Study Finds Gardasil Does Not Trigger Autoimmune Conditions After Vaccination</title>
            <link>http://www.medworm.com/index.php?rid=5633336&amp;cid=c_12_26_f&amp;fid=23292&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2FVpPBe8bfCO8%2F240798.php</link>
            <description>Gardasil, the human papillomavirus vaccine that is now recommended for male and female adolescents and young adults, does not trigger autoimmune conditions such as lupus, rheumatoid arthritis, type 1 diabetes or multiple sclerosis after vaccination in young women, according to a new study in the Journal of Internal Medicine. Kaiser Permanente researchers used electronic health records to conduct an observational safety study of 189,629 females aged 9 to 26 years old in California who were followed for six months after receiving each dose of the quadrivalent HPV vaccine in 2006-2008... (Source: Health News from Medical News Today)</description>
            <author>Health News from Medical News Today</author>
            <type>news</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5633336</comments>
            <pubDate>Fri, 27 Jan 2012 08:00:00 +0100</pubDate>
            <guid isPermaLink="false">5633336</guid>        </item>
    </channel>
</rss>

